Feed EVO
EV

Evotec SE

EVO · NASDAQ

$1.58 +1.94% (+$0.03)
1M -18.52%
Market Cap 490.2M €
P/E Ratio -
Div. Yield -
ROE 26.85%
Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/S 0.68x
P/B 0.74x
P/E N/A
Growth
16 /100
Declining
Rev. growth 0.26%
Book val. growth 11.84%
EPS growth N/A
Profitability
1 /100
Weak
Gross margin 10.34%
FCF margin 23.39%
Net margin 27.78%
Quality
6 /100
Poor
ROIC 10.41%
Asset turnover 0.46x
ROE 26.85%
Debt
54 /100
Moderate
Debt/Equity 0.71x
Int. coverage -15.75x
Current ratio 2.33x
Stability
45 /100
Moderate
Beta 1.26x
Profitable years 0
Rev. volatility 4.71%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre EVO
Online

Despre companie

Evotec SE (EVT) is a German pharmaceutical company focused on drug research and development. The company provides services to pharmaceutical and biotechnology firms in the areas of drug discovery, testing, and drug development. Evotec collaborates with various research institutions and pharmaceutical companies worldwide to identify and develop new drugs for different diseases. The company specializes in areas such as oncology, neurology, metabolic disorders, and infectious diseases. Evotec has a long history of research and innovation in the pharmaceutical industry, and its technologies and expertise are highly regarded in the world of medical research. Evotec SE (EVT) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company with a significant role in discovering new drugs and therapeutic approaches.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Christian Wojczewski

Employees

4,553

Headquarters

Hamburg

Evenimente viitoare

05 NOV.

Earnings

Upcoming earnings report

43d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.